Couples Say a Fertility Doctor Moved Their Embryos 160 Miles Without Permission, Then a Court Ordered Their Release

On March 3, 2026, 26 patients filed a lawsuit against California fertility specialist Brian David Acacio and Acacio Fertility Center, alleging their frozen embryos had been moved to another city without their knowledge or consent. A March 6 report by CafeMom detailed the allegations, including patients’ concerns that they could not get satisfactory answers about where their embryos were being stored. What began as a dispute over an unexpected clinic relocation soon developed into a broader legal battle involving medical licensing restrictions, unpaid rent, and demands for the return of reproductive material.

For the people involved, the stakes extended far beyond a disagreement with a medical provider. Their embryos had been created through fertility treatment, often after substantial financial and physical commitments, and were intended to help them have children. The lawsuit sought to secure the embryos’ return while holding the clinic and those involved accountable for the conduct alleged in court.

The Embryos Represented Years of Fertility Treatment

In vitro fertilization, commonly known as IVF, can involve hormone medications, egg retrieval, laboratory procedures, and embryo storage before a transfer can take place. Patients who spoke publicly about Acacio’s clinic described years of trying to become parents, with some having only a small number of embryos remaining. Those circumstances made uncertainty over the embryos’ whereabouts particularly serious for the families involved.

For many patients, stored embryos represented a remaining opportunity to pursue pregnancy without repeating every step of treatment. Their concerns were not limited to whether the clinic would cooperate with future appointments, but also whether their embryos had been handled appropriately during the move. The legal dispute therefore raised questions about both access to the embryos and the information patients needed to make decisions about their next treatment steps.

The Embryos Were Moved From Laguna Niguel to Bakersfield

According to the lawsuit, the relocation took place on or around December 17, 2025, when cryopreserved embryos were transferred from Acacio’s Laguna Niguel facility to a clinic location in Bakersfield, California. The distance between the two cities is approximately 160 miles, meaning patients’ reproductive material had been transported well outside the Orange County area where many had originally received treatment. The first amended complaint filed in Orange County Superior Court alleges that the move occurred without advance notice or authorization from the affected patients.

The complaint also raises concerns about the safeguards used during transportation. Plaintiffs allege they were not given the documentation they expected concerning the move, including records intended to establish how the embryos were handled. These remain allegations in the civil case, and the filings do not by themselves establish that any embryo was damaged during the relocation.

Unpaid Rent Was Part of the Clinic’s Financial Troubles

The move occurred as Acacio’s Laguna Niguel facility faced eviction proceedings over unpaid rent. A March 3 report by the Los Angeles Times reported that court records showed more than $243,000 in unpaid rent connected to the property, which had housed the clinic’s treatment facilities and embryo storage equipment. The lawsuit alleges that the financial problems contributed to the decision to relocate the embryos.

Patients had entrusted the clinic with reproductive material they expected to remain under appropriate care and storage arrangements. The alleged relocation took place against that backdrop of mounting financial pressure and the loss of the original premises. The central complaint was that patients should have been informed and given a say in how their embryos would be moved, regardless of the circumstances facing the clinic.

Some Patients Learned About the Move Only After Problems Arose

According to accounts presented by the plaintiffs, patients did not receive advance notification that their embryos were being transferred to Bakersfield. Some reportedly learned what had happened only after trying to schedule fertility procedures, while others heard about the relocation through other patients or information circulating online. The sudden discovery left them seeking confirmation of their embryos’ location and the arrangements for their continued storage.

The uncertainty also disrupted plans that patients had made around medical appointments and treatment schedules. Rather than proceeding directly to their next steps, some were left trying to determine whether the clinic could continue providing the services they expected. For families already managing the demands of fertility treatment, this created another obstacle in an already complicated process.

Patients Alleged That Getting Their Embryos Back Came With a Condition

The lawsuit’s allegations went beyond the original relocation. Patients claimed that when they sought the return of their embryos, Acacio’s office required them to sign a liability release before the material would be transferred to another facility. The proposed paperwork, according to the complaint, would have limited the patients’ ability to pursue claims related to possible harm associated with the embryos or their handling.

That demand put the families in a difficult position because obtaining access to their embryos was their immediate concern. They did not want to surrender potential legal rights simply to move their reproductive material to a provider they trusted. Their attorneys argued that the clinic should release the embryos without making that release conditional on patients giving up claims.

Medical Licensing Restrictions Added Another Layer to the Case

The dispute over the embryos emerged alongside a separate issue involving Acacio’s medical license. Court filings describe restrictions that took effect on October 8, 2025, following Medical Board of California proceedings involving substance use and concerns about his ability to practice safely. According to the filings, Acacio was subject to conditions that included abstaining from certain substances and complying with testing requirements.

On December 30, 2025, the medical board issued an order prohibiting him from practicing medicine after he tested positive for marijuana metabolites in violation of the restrictions, according to the legal filings. Patients later alleged that he had continued participating in medical care after the order took effect, including during the period in which some were preparing for embryo transfers. The allegations concerning treatment after the order are part of the broader dispute and should be distinguished from the documented dates of the licensing restrictions.

Marina Reyes Said Her Treatment Was Interrupted

Marina Reyes, a Bakersfield resident, was among the patients who described how the events affected her treatment plans. In reporting by ABC7 Los Angeles, Reyes said she underwent an invasive ultrasound on January 2, 2026, while preparing for a planned embryo transfer. She said the transfer was postponed before being canceled altogether.

Reyes also described the personal and financial toll of the experience, explaining that the disruption affected her emotionally, physically, and financially. Her account illustrated how the allegations extended beyond the question of where embryos were being kept, reaching patients’ ongoing medical care and plans for starting a family. The lawsuit alleges that patients were not properly informed about the licensing situation while treatment was continuing.

Bernice Cervantes Described the Uncertainty Surrounding Her Embryos

Another patient, Bernice Cervantes, publicly expressed concern about not knowing the location and condition of her embryos. Cervantes and her husband, Curtis Hanson, were among those who joined the lawsuit after entrusting their fertility treatment to Acacio. Their account reflected a central concern shared by other plaintiffs: they wanted reliable information about their embryos and a clear path toward transferring them to another provider.

Cervantes also spoke about the care she had taken when choosing a fertility specialist, explaining that she had researched her options before settling on Acacio. The situation she later described was markedly different from the treatment journey she had expected. Her public comments helped bring attention to the human consequences alleged in the case without resolving the underlying factual questions about embryo handling or responsibility.

The Lawsuit Sought Answers and Legal Accountability

The initial lawsuit was filed in Orange County Superior Court on March 3, 2026, against Acacio, Acacio Fertility Center, and other named defendants. Its allegations included unauthorized relocation of embryos, lack of informed consent, and refusal to release reproductive material without liability waivers. The plaintiffs asked the court to intervene so they could regain control of their embryos and move them to facilities of their choosing.

The complaint also challenged the alleged failure to disclose important information about the clinic and Acacio’s professional status. The families’ attorneys maintained that patients should not have had to discover these problems through canceled appointments or informal communications with others. As with other civil litigation, the filing sets out the plaintiffs’ claims rather than a final judicial determination of liability.

Concerns About Storage and Transportation Remained Unresolved

Embryos preserved through IVF depend on specialized cryogenic storage systems and carefully controlled handling. In their lawsuit, patients alleged that they were not provided sufficient documentation to establish the safeguards used during the relocation. They questioned whether the embryos had been maintained appropriately and whether they could confidently continue treatment using the stored material.

Those questions were especially significant because the relocation involved reproductive material that could not simply be replaced without further medical treatment. However, the allegations about transportation procedures should not be confused with proof that the embryos were damaged or had become unusable. The litigation sought both access to the material and accountability for any harm that could ultimately be established.

Attorneys Sought to Stop the Use of Liability Waivers

As the dispute continued, the patients’ attorneys sought court intervention to prevent the clinic from conditioning the release of embryos on liability-related paperwork. On May 5, 2026, Fertility Law Group filed a motion for a preliminary injunction asking for the immediate and unconditional release of its clients’ embryos and other genetic material. The motion sought to ensure that patients could transfer their material to other facilities without waiving potential legal claims.

The requested relief addressed the immediate practical problem facing the plaintiffs while the wider lawsuit continued. Patients needed a way to regain access to their embryos without having to resolve every allegation in the case first. The legal proceedings therefore developed on two tracks: obtaining the release of the reproductive material and pursuing claims over the events that had led to the dispute.

A June Court Order Required the Embryos to Be Released

A major development came on June 4, 2026, when the parties’ agreement concerning the release of the plaintiffs’ reproductive material was entered as a court order. The stipulation and order filed in Orange County Superior Court allowed plaintiffs to have their embryos, eggs, sperm, and other genetic material released and transported to facilities of their choosing. It also prohibited the defendants from making the release conditional on liability waivers or similar restrictions.

The order was significant because it addressed the immediate obstacle that had prompted the motion for court intervention. Patients could pursue the transfer of their reproductive material without agreeing to give up potential claims against the defendants. The order did not, however, decide whether the defendants were liable for the alleged conduct or resolve the broader claims in the lawsuit.

The Case Expanded Beyond Its Original Group of Plaintiffs

The number of families represented in the litigation grew after the original filing. According to an August 2026 case update from Fertility Law Group, the firm was then representing 134 families, comprising more than 250 people, in connection with the allegations involving Acacio Fertility Center. That figure reflects the law firm’s reported client representation as the litigation developed, not a finding that every allegation had been proven in court.

The expansion suggested that the problems described in the initial complaint had prompted other patients to come forward with concerns about their own treatment experiences. The firm’s update said it continued to hear from additional people who believed they might have been affected. As the group grew, the case became broader than the initial emergency over the location and release of the embryos.

The Immediate Fight Over Access Changed, but the Lawsuit Continued

The June order addressed patients’ ability to obtain their reproductive material without signing away potential legal rights. However, an order allowing the release of embryos is not the same as a final determination about how the relocation was handled or whether any patient suffered compensable harm. Those questions remained part of the ongoing civil litigation as of the law firm’s August update.

The families’ claims also involve issues separate from the immediate return of the embryos, including the alleged lack of consent and the treatment of patients during the period surrounding the clinic’s licensing restrictions. The defendants’ legal responsibility must be determined through the proceedings rather than assumed from the allegations alone. The court’s intervention resolved an urgent practical barrier while leaving the larger dispute to continue.

The Families’ Search for Answers Went Beyond Finding Their Embryos

For the patients involved, gaining access to their embryos was a crucial step toward regaining control over their fertility plans. The legal order created a route for transferring the reproductive material to other facilities without the contested liability waivers, although individual medical circumstances and treatment decisions would still have to be addressed. The larger case continues to concern what happened before and during the relocation, and whether the plaintiffs are entitled to compensation.

The episode also illustrates the level of trust involved when patients place their reproductive material in a fertility clinic’s care. Families rely on clear communication about storage, consent, and the arrangements that govern their treatment, particularly when their plans depend on embryos preserved for future use. For the people represented in this case, the court order provided a concrete change in their ability to seek the return of their material, but the broader questions of accountability remained unresolved.